European Regulators Move to Revoke Avacopan Authorization

(MedPage Today) -- A European Medicines Agency (EMA) committee recommended pulling the marketing authorization for avacopan (Tavneos) following a review over data integrity concerns in the vasculitis drug's key supporting trial.
Due to breaches...